EFPIA - NEWSLETTER

EFPIA Newsletter 15 November 2018

News

15 November 2018 EFPIA Reaction to publication for the proposed Brexit Withdrawal Agreement

EFPIA notes the publication of the withdrawal agreement under which terms the United Kingdom would leave the European...

15 November 2018 Delivering more for patients and health systems through outcomes-measurement

A seminar hosted by the ABPI, ICHOM and EFPIA

Blogs

15 November 2018 Antimicrobial Stewardship: Our contribution to #KeepAntibioticsWorking (Guest blog)

A guest blog by Claudie Charbonneau, Senior Director, Patient & Health Impact and Infectious Diseases Global Team Lead...

15 November 2018 Global action on antibiotic awareness must progress (Guest blog)

A guest blog by Zuzana Kusynová, policy advisor and project manager at FIP

Infographic: Why new incentives are needed to develop antibiotics

Infographic: Why new incentives are needed to develop antibiotics 05 April 2018 (Publications)

As of May 2017, 51 antibiotics and 11 biologicals were in the clinical pipeline. Only five are expected to reach the...

What we are reading

By 2050, superbugs may cost the economy $100 trillion 15 November 2018 (By Thomas Cueni, Director General, IFPMA)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶